Join to view full profile
350 Engle St# 1Englewood, NJ 07631
Phone+1 201-568-5250
Fax+1 201-568-5096
Dr. Schleider is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Michael Schleider is an oncologist in Englewood, NJ and is affiliated with multiple hospitals in the area, including Englewood Hospital and Medical Center and Holy Name Medical Center. He received his medical degree from Perelman School of Medicine at the University of Pennsylvania and has been in practice 48 years. He specializes in hematologic oncology.
Education & Training
New York Presbyterian Hospital (Columbia Campus)Fellowship, Hematology and Medical Oncology, 1974 - 1977- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1972 - 1974
University of ChicagoInternship, Internal Medicine, 1969 - 1970
Perelman School of Medicine at the University of PennsylvaniaClass of 1969
Certifications & Licensure
CA State Medical License 1975 - Present
NY State Medical License 1972 - 2028
NJ State Medical License 1975 - 2027
PA State Medical License 1975 - 1992
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Inside Jersey Top Doctors for Cancer Castle Connolly, 2012-2014
- Inside Jersey Magazine Top Doctors Castle Connolly, 2010-2014
- Top Doctors: New York Metro Area Castle Connolly, 2003-2007, 2009-2014
Clinical Trials
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Feb 28
- Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer Start of enrollment: 2015 Jul 26
Publications & Presentations
PubMed
- 442 citationsA clinical study of the lupus anticoagulantMichael A. Schleider, Ralph L. Nachman, Eric A. Jaffe, Morton Coleman
Blood. 1976-10-01
Professional Memberships
- Member
Other Languages
- Hebrew
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
